Rani Therapeutics Holdings Inc. (RANI)
NASDAQ · Healthcare
Rani Therapeutics Holdings Inc. Operating Income 2020–2025
Rani Therapeutics Holdings Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Rani Therapeutics Holdings Inc. operating income for the quarter ending March 31, 2026 was -8.3 M, a 30.58% decrease year-over-year.
- Rani Therapeutics Holdings Inc. operating income for the twelve months ending March 31, 2026 was -38.1 M, a 30.32% decrease year-over-year.
- Rani Therapeutics Holdings Inc. annual operating income for 2025 was -38.3 M, a 28.14% decrease from 2024.
- Rani Therapeutics Holdings Inc. annual operating income for 2024 was -53.3 M, a 19.34% decrease from 2023.
- Rani Therapeutics Holdings Inc. annual operating income for 2023 was -66.1 M, a 4.17% increase from 2022.
- Rani Therapeutics Holdings Inc. annual operating income for 2022 was -63.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rani Therapeutics Holdings Inc. Operating Income — FAQ
Rani Therapeutics Holdings Inc. (RANI) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Rani Therapeutics Holdings Inc.'s operating income?
Rani Therapeutics Holdings Inc. (RANI) reported operating income of -$38M for fiscal 2025.
Where can I see RANI's operating income history?
The chart and table above show Rani Therapeutics Holdings Inc.'s operating income by year and by quarter, including the growth rate.